SSY GROUP LIMITED

Insiders SSY Group Limited

Equities

2005

KYG8406X1034

Market Closed - Hong Kong S.E. Other stock markets 09:08:07 18/06/2024 BST			5-day change	1st Jan Change
4.75 ^HKD	+0.64%		+1.93%	-3.85%

09:33am	SSY’s Hypertension Drug Passes Chinese Regulator’s Consistency Eval; Obtains Go-Ahead for Production, Registration	MT
06:01am	SSY Group Limited Obtains Approval for Drug Production and Registration for Esmolol Hydrochloride and Sodium Chloride Injection from National Medical Products Administration of China	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

SSY Group Limited Appoints Liu Wenjun as Non-Executive Director	01-19	CI
SSY Group Limited Announces Resignation of Feng Hao as Non-Executive Director, Effective from 1 November 2023	11-01	CI
SSY Group Limited Announces the Retirement of Mr. Leung Chong Shun as Independent Non-Executive Director, Chairman of the Remuneration Committee of the Company, A Member of the Audit Committee of the Company and A Member of the Nomination Committee	19/05/23	CI
Fortress Minerals' CFO Resigns	12/04/23	MT
SSY Group Limited Announces Appointment of Jiang Guangce as an Independent Non-Executive Director and Member of Audit Committee, Nomination Committee and Remuneration Committee, with Effect from 1 January 2023	28/12/22	CI
Fortress Minerals Appoints CFO	14/10/22	MT
SSY Group Limited Announces Board Changes	27/08/21	CI
SSY Group Limited Appoints Feng Hao as Non-Executive Director	24/11/17	CI
Lijun International Pharmaceutical Co., Ltd. will Change its Name to SSY Group Limited	22/06/15	CI
Lijun International Pharmaceutical Co., Ltd. Announces Executive Changes with Effect from 1 April 2015	01/04/15	CI
Lijun International Pharmaceutical Co., Ltd. Announces Board Changes	15/12/14	CI
Lijun International Pharmaceutical Co., Ltd. Announces Resignation of Mr. Wu Qin as an Executive Director and Chairman of the Board	08/06/14	CI
Lijun International Pharmaceutical Co. Ltd. Announces Executive Changes	18/12/12	CI
Lijun International Pharmaceutical Co Ltd. Resignation of Zhang Guifu as Executive Director, Effective from 5 April 2012	05/04/12	CI
Lijun International Pharmaceutical Co Ltd. Announces Formation of Nomination Committee	23/03/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW